NGS MRD Negativity on Day 28 after Brexu Cel in Adults with R/R ALL Is Associated with Favorable Progression Free Survival
Yannis K. Valtis(Brigham and Women's Hospital), Aaron C. Logan(University of California, San Francisco), Joshua Sasine(Cedars-Sinai Medical Center), Simone E. Dekker(Oregon Health & Science University), Matthew L. Ulrickson, Paul Shaughnessy(CHRISTUS Transplant Institute), Navneet S. Majhail(Sarah Cannon), Divya Koura(University of California San Diego), Marlise R. Luskin(Dana-Farber Cancer Institute), Vinod Pullarkat(City of Hope), Bijal Shah(Boston College), Jacob Boccucci(Augusta University Health), Luke Mountjoy(Colorado Blood Cancer Institute), Caspian Oliai(APLA Health), Jessica Leonard(Oregon Health & Science University), Vishal Gupta(University of California, Los Angeles), Evandro D. Bezerra(Cleveland Clinic), Tamer Othman(City Of Hope National Medical Center), Ibrahim Aldoss(City of Hope), Michael R. Grunwald(Levine Cancer Institute), Gregory W. Roloff(University of Chicago), Noam E. Kopmar(University of Washington), Evan C. Chen(Dana-Farber Cancer Institute), Rasmus T. Hoeg(University of California, Davis), LaQuisa C. Hill(Baylor College of Medicine), Ibrahim N. Muhsen, Shahbaz Malik, Vamsi Kota(Augusta University), Caitlin Guzowski(Northside Hospital), Talal Hilal(WinnMed), Chenyu Lin(Duke University), Ryan D. Cassaday(University of Washington), Minoo Battiwalla(Sarah Cannon), Kaitlyn C. Dykes(University of California San Diego), John A. Mathews(Macquarie University), David Nemirovsky(Memorial Sloan Kettering Cancer Center), Anjali S. Advani(Cleveland Clinic), Ran Reshef(Abramson Cancer Center), Timothy E. O’Connor(University of Northern Iowa), Nikeshan Jeyakumar(Stanford Blood Center), Amy Zhang, Mohamed Ahmed(The University of Texas MD Anderson Cancer Center), Sumithira Vasu(The Ohio State University), Katherine C. Sutherland(Stanford University), Sean Devlin(Memorial Sloan Kettering Cancer Center), Katharine Miller(Stanford University), Melhem Solh(Johns Hopkins Hospital), Ali Al Darobi(The University of Texas MD Anderson Cancer Center), Rawan Faramand(Moffitt Cancer Center)
Cited by 0
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
|New England Journal of Medicine|2023|437